Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and ...

Oct 26 (Reuters) - Merck's experimental targeted drug helped women with advanced endometrial cancer live longer and kept ...

A preclinical Mayo Clinic study found that MAPK inhibitors restored TSHR on anaplastic thyroid cancer cells and improved ...

More than 30 years after the direct connection was established between the molecular machinery controlling cell division and ...

A new analysis of a phase 3 clinical trial found that the targeted drug daraxonrasib improved survival compared with standard ...

Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new ...

Biotech Insider News Commentary - An mRNA-based cancer therapy designed around each patient’s own tumor has delivered positive Phase 3 results. On October 22, Merck and Moderna announced detailed ...

A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

This week, we learned that surgery removed the cancer entirely and he wouldn’t need further treatment. Not so long ago, a ...

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and ...